Abstract
Geste antagonistes are usually considered typical of primary dystonia, although rarely they have been described in secondary/heredodegenerative dystonias. We have recently come across a particular geste antagoniste in 5 of 10 patients with pantothenate kinase‐associated neurodegeneration (PKAN) who had prominent oromandibular involvement with severe jaw‐opening dystonia. It consists of touching the chin with both hands characteristically clenched into a fist with flexion at the elbows. Because of the resemblance of this geste antagoniste with the praying‐like posture of Mantis religiosa, we coined the term “mantis sign.” Reviewing videos of PKAN cases in literature, including what is considered the first cinematic depiction of a case of this disorder, 3 additional cases with akin maneuvers were identified. In contrast, examining 205 videos of non‐PKAN dystonic patients from our database for the presence of a similar maneuver was unrevealing. Thus, we consider the mantis sign to be quite typical of PKAN and propose it to be added as a clinical hint toward diagnosis.
Keywords: PKAN, dystonia, geste antagoniste
The movement disorder of dystonia is characterized by sustained or intermittent muscle contractions that lead to abnormal and often repetitive movements and/or postures.1 In some cases, the use of simple maneuvers, usually related to ephaptic contact with the dystonic body region, lead to an impressive temporary improvement of symptoms. These maneuvers are called gestes antagonistes (GAs) or sensory tricks.2, 3 GAs are usually considered in the context of primary dystonias.1, 3 However, their presence has also been described in secondary4 as well as heredodegenerative conditions to include pantothenate kinase‐associated neurodegeneration (PKAN).5 In addition to typical GAs, atypical tricks have also been described in the literature (for review, see a previous work6). Forcible tricks (GA with additional use of force) are considered atypical sensory tricks and have been reported to be more prevalent in severe forms of dystonia than classic sensory tricks.7
We have recently observed, in 5 of 10 genetically proven PKAN patients (4 of them previously published elsewhere),8 a characteristic GA maneuver associated with severe jaw‐closing or ‐opening dystonia and retrocollis. It consisted of repetitive chin touching with the dorsum of one or both hands, which were clenched in dystonic flexion (see Video, Segment 1; Fig. 1). In addition to light touch in all cases, force was applied during the maneuver onto the chin to correct the abnormal jaw position (atypical GA). Reviewing available videos of PKAN cases in the literature,9, 10 3 additional cases with akin maneuvers were identified, including what is considered the first cinematic depiction of a case of this disorder published by Vincent and van Bogaert10 (see Video, Segments 2 and 3). The phenomenology of these “forcible tricks” resembled the praying‐like posture of the praying mantis insect. Therefore, we propose naming this specific GA described here the “mantis sign.”
The classic phenotype of PKAN resulting from mutations in the PANK2 gene is characterized by early‐onset generalized dystonia with prominent oromandibular involvement leading to dystonic jaw opening or jaw closing, anarthria, and severe dysphagia.11 Lingual dystonia with tongue protrusion and repetitive touching of the face have been suggested as helpful clues for the diagnosis.5, 11 Dystonic opisthotonus was recently suggested to be a red flag for clinicians to suspect neurodegeneration with brain iron accumulation syndromes.12 Although typical GAs have been previously demonstrated in PKAN patients,5, 9 and are also shown in one of our cases presented here (gentle forehead touch to overcome blepharospam: case 4; see Video), these are rare. It thus appears that the mantis sign proposed here could be an additional diagnostic clue for PKAN. Reviewing 205 videos of our patients with other forms of dystonias, including 10 with prominent oromandibular involvement and, particularly, jaw‐opening/‐closing dystonia, but also videos from the literature we were not able to identify a similar maneuver. Whether it has been underreported or is indeed specific for PKAN is still thus unclear. However, clinicians should be aware and recognize the mantis sign proposed here as another red flag facilitating diagnostic considerations and prompting further examinations to include neuroimaging for the search of additional characteristic signs.5, 11
Author Roles
(1) Research Project: A. Conception, B. Organization, C. Execution; (2) Statistical Analysis: A. Design, B. Execution, C. Review and Critique; (3) Manuscript: A. Writing of the First Draft, B. Review and Critique.
I.N.P.: 1A, 3A, 3B
N.K.: 1B, 1C, 3A, 3B
C.G.: 1A, 1C, 3A, 3B
M.S.: 1B, 3B
N.D.: 1B, 3B
K.P.B.: 3B
V.S.K.: 1A, 1B, 1C, 3B
Disclosures
Funding Sources and Conflicts of Interest: The research is funded by the Ministry of Science, Republic of Serbia (project no.: 175090). The authors report no conflicts of interest.Financial Disclosures for previous 12 months: I.N.P. has received honoraria from Boehringer Ingelheim and GlaxoSmithKline (GSK) and been employed by Institute of Neurology, CCS, Belgrade. N.K. has been employed by Institute of Neurology, CCS, Belgrade. C.G. has received grants for travel from Actelion, Ipsen, Pharm Allergan and Merz Pharmaceuticals and been employed by Institute of Neurology, University College London (UCL), London, UK. M.S. has received honoraria from Boehringer Ingelheim and GSK and has been employed by Institute of Neurology, CCS, Belgrade. K.P.B. has received personal compensation for serving on the scientific advisory boards of GSK and Boehringer Ingelheim; funding for travel from GSK, Orion Corporation, Ipsen, and Merz Pharmaceuticals, LLC; speaker honoraria from GSK, Ipsen, Merz Pharmaceuticals, LLC, and Sun Pharmaceutical Industries Ltd.; grant support through Dystonia Society UK, the Wellcome Trust MRC strategic neurodegenerative disease initiative award (reference no.: WT089698), a grant from the Dystonia Coalition, and a grant from Parkinson's UK (reference no.: G‐1009); received research support from Ipsen and from the Halley Stewart Trust; has been employed by Institute of Neurology, UCL, London, UK; receives royalties from the Oxford University Press; and serves on the editorial boards of Movement Disorders and Therapeutic Advances in Neurological Disorders. V.S.K. has served on the regional advisory board of Boehringer Ingelheim and the local advisory board of Pfizer; has received payment for lectures from Novartis, Boehringer, Abott, GSK, Pfizer, Hemofarm‐Stada, and Akaloid; has received grant support from the MNTR Serbia project (grant no.: 175090); and has been employed by Institute of Neurology, CCS, Belgrade. N.D. has been employed by Institute of Neurology, CCS, Belgrade.
Supporting information
Relevant disclosures and conflicts of interest are listed at the end of this article.
References
- 1. Albanese A, Bhatia K, Bressman SB, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord 2013;28:863–873. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Albanese A, Lalli S. Is this dystonia? Mov Disord 2009;24:1725–1731. [DOI] [PubMed] [Google Scholar]
- 3. Martino D, Liuzzi D, Macerollo A, Aniello MS, Livrea P, Defazio G. The phenomenology of the geste antagoniste in primary blepharospasm and cervical dystonia. Mov Disord 2010;25:407–412. [DOI] [PubMed] [Google Scholar]
- 4. Molho ES, Feustel PJ, Factor SA. Clinical comparison of tardive and idiopathic cervical dystonia. Mov Disord 1998;13:486–489. [DOI] [PubMed] [Google Scholar]
- 5. Thomas M, Hayflick SJ, Jankovic J. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallerworden‐Spatz syndrome) and panthotenate kinase‐associated neurodegeneration. Mov Disord 2004;19:36–42. [DOI] [PubMed] [Google Scholar]
- 6. Ramos VF, Karp BI, Hallett M. Tricks in dystonia: ordering the complexity. J Neurol Neurosurg Psychiatry 2014. doi: 10.1136/jnnp-2013-306971. [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Ochudło S, Drzyzga K, Drzyzga LR, Opala G. Various patterns of gestes antagonistes in cervical dystonia. Parkinsonism Relat Disord 2007;13:417–420. [DOI] [PubMed] [Google Scholar]
- 8. Hartig MB, Hörtnagel K, Garavaglia B, et al. Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation. Ann Neurol 2006;59:248–256. [DOI] [PubMed] [Google Scholar]
- 9. Adamovicova M, Jech R, Urgosik D, Spackova N, Krepelova A. Pallidal stimulation in siblings with pantothenate kinase‐associated neurodegeneration: four‐year follow‐up. Mov Disord 2011;26:184–187. [DOI] [PubMed] [Google Scholar]
- 10. Van Craenenbroeck A, Gebruers M, Martin JJ, Cras P. Hallervorden‐Spatz disease: historical case presentation in the spotlight of nosological evolution. Mov Disord 2010;25:2486–2492. [DOI] [PubMed] [Google Scholar]
- 11. Schneider SA, Hardy J, Bhatia KP. Syndromes of neurodegeneration with brain iron accumulation (NBIA): an update on clinical presentations, histological and genetic underpinnings, and treatment considerations. Mov Disord 2012;27:42–53. [DOI] [PubMed] [Google Scholar]
- 12. Stamelou M, Lai SC, Aggarwal A, et al. Dystonic opisthotonus: a “red flag” for neurodegeneration with brain iron accumulation syndromes? Mov Disord 2013;28:1325–1329. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.